Published in J Clin Endocrinol Metab on May 01, 2003
Role of sex steroids in the regulation of bone morphology in men. The MINOS study. Osteoporos Int (2004) 0.96
An update on male hypogonadism therapy. Expert Opin Pharmacother (2014) 0.80
Male hormonal contraception: hope and promise. Lancet Diabetes Endocrinol (2016) 0.78
Differential effects of androgens and estrogens on bone turnover in normal men. J Clin Endocrinol Metab (2003) 2.54
Involutional osteoporosis. N Engl J Med (1986) 8.20
DHEA in elderly women and DHEA or testosterone in elderly men. N Engl J Med (2006) 7.90
Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res (2007) 6.76
Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev (2002) 6.38
Osteoporosis: now and the future. Lancet (2011) 5.81
Perspective. How many women have osteoporosis? J Bone Miner Res (1992) 4.99
Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen. J Clin Endocrinol Metab (1998) 4.28
Circulating osteoblast-lineage cells in humans. N Engl J Med (2005) 4.19
Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Intern Med (1992) 4.19
Population-based study of age and sex differences in bone volumetric density, size, geometry, and structure at different skeletal sites. J Bone Miner Res (2004) 4.02
Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. Comparison with conventional therapy. N Engl J Med (1982) 3.77
Differential changes in bone mineral density of the appendicular and axial skeleton with aging: relationship to spinal osteoporosis. J Clin Invest (1981) 3.60
The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res (2000) 3.38
Fat tissue, aging, and cellular senescence. Aging Cell (2010) 3.34
Epidemiology of vertebral fractures in women. Am J Epidemiol (1989) 3.27
Role of RANK ligand in mediating increased bone resorption in early postmenopausal women. J Clin Invest (2003) 3.09
Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. J Clin Invest (2000) 2.94
Epidemiology of fractures of the proximal femur in Rochester, Minnesota. Clin Orthop Relat Res (1981) 2.93
Changes in bone mineral density of the proximal femur and spine with aging. Differences between the postmenopausal and senile osteoporosis syndromes. J Clin Invest (1982) 2.92
Fractures after rheumatoid arthritis. A population-based study. Arthritis Rheum (1984) 2.85
Evidence of estrogen receptors in normal human osteoblast-like cells. Science (1988) 2.85
Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease. Endocr Rev (2007) 2.82
Epidemiologic features of humeral fractures. Clin Orthop Relat Res (1982) 2.79
A population-based assessment of rates of bone loss at multiple skeletal sites: evidence for substantial trabecular bone loss in young adult women and men. J Bone Miner Res (2008) 2.76
Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis. Endocrinology (1999) 2.69
Interleukin-1beta and tumor necrosis factor-alpha, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells. Bone (1999) 2.69
Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinology (1999) 2.65
Long-term fracture prediction by bone mineral assessed at different skeletal sites. J Bone Miner Res (1993) 2.59
Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw. J Rheumatol (2008) 2.57
Secular trends in the incidence of hip fractures. Calcif Tissue Int (1987) 2.40
Regulation of bone formation by osteoclasts involves Wnt/BMP signaling and the chemokine sphingosine-1-phosphate. Proc Natl Acad Sci U S A (2008) 2.39
Cancellous bone remodeling in type I (postmenopausal) osteoporosis: quantitative assessment of rates of formation, resorption, and bone loss at tissue and cellular levels. J Bone Miner Res (1990) 2.39
Osteoporosis and the risk of hip fracture. Am J Epidemiol (1986) 2.35
Effects of suppression of follicle-stimulating hormone secretion on bone resorption markers in postmenopausal women. J Clin Endocrinol Metab (2010) 2.33
For estimating creatinine clearance measuring muscle mass gives better results than those based on demographics. Kidney Int (2009) 2.32
Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells. Endocrinology (1999) 2.27
Vertebral fractures predict subsequent fractures. Osteoporos Int (1999) 2.24
Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients: effect of age and dietary calcium. J Clin Invest (1979) 2.21
Evidence for two distinct syndromes of involutional osteoporosis. Am J Med (1983) 2.17
Incidence of Colles' fracture in a North American community. Am J Public Health (1982) 2.17
Isolation and characterization of osteoblast precursor cells from human bone marrow. J Bone Miner Res (1996) 2.16
Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993-2001: an update on the changing epidemiology of the disease. J Bone Miner Res (2005) 2.15
Contribution of in vivo structural measurements and load/strength ratios to the determination of forearm fracture risk in postmenopausal women. J Bone Miner Res (2007) 2.11
Fracture risk in type 2 diabetes: update of a population-based study. J Bone Miner Res (2008) 2.07
Bone turnover across the menopause transition: correlations with inhibins and follicle-stimulating hormone. J Clin Endocrinol Metab (2006) 2.04
The role of the immune system in the pathophysiology of osteoporosis. Immunol Rev (2005) 2.03
Relationship of glucocorticoid dosage to serum bone Gla-protein concentration in patients with rheumatologic disorders. Arthritis Rheum (1990) 2.03
Age-dependence of femoral strength in white women and men. J Bone Miner Res (2010) 2.03
Rates of bone loss in the appendicular and axial skeletons of women. Evidence of substantial vertebral bone loss before menopause. J Clin Invest (1986) 2.01
Risk factors for spinal osteoporosis in men. Am J Med (1983) 2.00
Relation of age, gender, and bone mass to circulating sclerostin levels in women and men. J Bone Miner Res (2011) 2.00
Development and characterization of a conditionally immortalized human fetal osteoblastic cell line. J Bone Miner Res (1995) 1.97
Structural determinants of vertebral fracture risk. J Bone Miner Res (2007) 1.97
Epidemiology of sarcopenia. J Am Geriatr Soc (2000) 1.97
Bone density and structure in healthy postmenopausal women treated with exemestane for the primary prevention of breast cancer: a nested substudy of the MAP.3 randomised controlled trial. Lancet Oncol (2012) 1.94
Skeletal effects of estrogen. Endocr Rev (1994) 1.91
Relative contributions of aging and estrogen deficiency to postmenopausal bone loss. N Engl J Med (1984) 1.90
Bisphosphonate associated osteonecrosis of the jaw. J Rheumatol (2009) 1.90
In vivo assessment of bone quality in postmenopausal women with type 2 diabetes. J Bone Miner Res (2014) 1.90
Identification of a novel TGF-beta-regulated gene encoding a putative zinc finger protein in human osteoblasts. Nucleic Acids Res (1995) 1.89
Classification of vertebral fractures. J Bone Miner Res (1991) 1.89
Mechanisms of sex steroid effects on bone. Biochem Biophys Res Commun (2005) 1.89
Effects of parathyroid hormone treatment on circulating sclerostin levels in postmenopausal women. J Clin Endocrinol Metab (2010) 1.87
Role of calcium intake in modulating age-related increases in parathyroid function and bone resorption. J Clin Endocrinol Metab (1996) 1.79
Bone density and fracture risk in men. J Bone Miner Res (1998) 1.77
Estrogen receptor isoform-specific regulation of endogenous gene expression in human osteoblastic cell lines expressing either ERalpha or ERbeta. J Cell Biochem (2003) 1.76
Bone structure at the distal radius during adolescent growth. J Bone Miner Res (2009) 1.74
The endogenous selective estrogen receptor modulator 27-hydroxycholesterol is a negative regulator of bone homeostasis. Endocrinology (2010) 1.74
Comparison of sex steroid measurements in men by immunoassay versus mass spectroscopy and relationships with cortical and trabecular volumetric bone mineral density. Osteoporos Int (2008) 1.73
Prevalence and incidence of vertebral deformities. Osteoporos Int (1993) 1.72
Assessing forearm fracture risk in postmenopausal women. Osteoporos Int (2009) 1.71
Increase in serum bone gamma-carboxyglutamic acid protein with aging in women. Implications for the mechanism of age-related bone loss. J Clin Invest (1983) 1.69
Immunologic differentiation of primary hyperparathyroidism from hyperparathyroidism due to nonparathyroid cancer. J Clin Invest (1971) 1.68
Avian osteoclasts as estrogen target cells. Proc Natl Acad Sci U S A (1991) 1.65
Diagnosis of osteoporosis: usefulness of photon absorptiometry at the radius. J Nucl Med (1977) 1.63
Targeting bone remodeling for the treatment of osteoporosis: summary of the proceedings of an ASBMR workshop. J Bone Miner Res (2009) 1.59
Role of circulating osteogenic progenitor cells in calcific aortic stenosis. J Am Coll Cardiol (2012) 1.59
Mesenchymal stem cells for bone repair and metabolic bone diseases. Mayo Clin Proc (2009) 1.59
Age- and sex-specific differences in the factor of risk for vertebral fracture: a population-based study using QCT. J Bone Miner Res (2006) 1.58
Inhibition of hydroxyapatite crystal growth by bone-specific and other calcium-binding proteins. Biochemistry (1986) 1.57
Relationship between body composition and bone mass in women. J Bone Miner Res (1996) 1.57
Osteocalcin expression by circulating endothelial progenitor cells in patients with coronary atherosclerosis. J Am Coll Cardiol (2008) 1.55
Regulation of circulating sclerostin levels by sex steroids in women and in men. J Bone Miner Res (2011) 1.53
Effects of estrogen with micronized progesterone on cortical and trabecular bone mass and microstructure in recently postmenopausal women. J Clin Endocrinol Metab (2013) 1.51
Histomorphometric analysis of iliac crest bone biopsies in placebo-treated versus fluoride-treated subjects. Osteoporos Int (1995) 1.51
Effect of combined therapy with sodium fluoride, vitamin D and calcium in osteoporosis. Am J Med (1972) 1.50
Differential effects of endocrine dysfunction on the axial and the appendicular skeleton. J Clin Invest (1982) 1.48
Emerging therapeutic opportunities for skeletal restoration. Nat Rev Drug Discov (2011) 1.48
Estrogen receptor alpha and beta heterodimers exert unique effects on estrogen- and tamoxifen-dependent gene expression in human U2OS osteosarcoma cells. Mol Endocrinol (2005) 1.48
Mediators of the biphasic responses of bone to intermittent and continuously administered parathyroid hormone. J Cell Biochem (2003) 1.48
Role of low levels of endogenous estrogen in regulation of bone resorption in late postmenopausal women. J Bone Miner Res (2002) 1.46
Differentiation of human marrow stromal precursor cells: bone morphogenetic protein-2 increases OSF2/CBFA1, enhances osteoblast commitment, and inhibits late adipocyte maturation. J Bone Miner Res (1999) 1.44
Bone densitometry and clinical decision-making in osteoporosis. Ann Intern Med (1988) 1.43
The expression of osteoprotegerin and RANK ligand and the support of osteoclast formation by stromal-osteoblast lineage cells is developmentally regulated. Endocrinology (2000) 1.43
Colles' fracture and subsequent hip fracture risk. Clin Orthop Relat Res (1983) 1.43
Changes in Runx2/Cbfa1 expression and activity during osteoblastic differentiation of human bone marrow stromal cells. J Bone Miner Res (2003) 1.42
Radioimmunoassay of parathyroid hormone in hypercalcemic patients with malignant disease. Am J Med (1974) 1.42
Measurement of bone mineral content in human vertebrae and hip by dual photon absorptiometry. Radiology (1980) 1.42
Fracture risk following bilateral orchiectomy. J Urol (2003) 1.41
Leptin reduces ovariectomy-induced bone loss in rats. Endocrinology (2001) 1.40